This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Towards effective and safe immunotherapy after allogeneic stem cell transplantation: identification of hematopoietic-specific minor histocompatibility antigen UTA2-1
Leukemia Open Access 01 October 2012
-
Adoptively transferred human lung tumor specific cytotoxic T cells can control autologous tumor growth and shape tumor phenotype in a SCID mouse xenograft model
Journal of Translational Medicine Open Access 25 June 2007
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Kolb H, Schattenberg A, Goldman J, Hertenstein B, Jacobsen N, Arcese W et al. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia. Blood 1995; 86: 2041–2050.
Marijt W, Heemskerk M, Kloosterboer F, Goulmy E, Kester M, van der Horn M et al. Hematopoiesis-restricted minor histocompatibilty antigens HA-1- or HA-2-specific T cells can induce complete remissions of relapsed leukemia. Proc Natl Acad Sci USA 2003; 100: 2742–2747.
Hambach L, Goulmy E . Immunotherapy of cancer through targeting of minor histocompatibility antigens. Curr Opin Immunol 2005; 17: 202–210.
Nijmeijer B, Willemze R, Falkenburg J . An animal model for human cellular immunotherapy: specific eradication of human acute lymphoblastic leukemia by cytotoxic T lymphocytes. Blood 2002; 100: 654–660.
Mutis T, Verdijk R, Schrama E, Esendam B, Brand A, Goulmy E . Feasibility of immunotherapy of relapsed leukemia with ex vivo-generated cytotoxic T lymphocytes specific for hematopoietic system-restricted minor histocompatibility antigens. Blood 1999; 93: 2336–2341.
Bonnet D, Warren E, Greenberg P, Dick J, Riddell S . CD8+ minor histocompatibility antigen-specific cytotoxic T lymphocyte clones eliminate human acute myeloid leukemia stem cells. Proc Natl Acad Sci USA 1999; 96: 8639–8644.
Verra N, Jorritsma A, Weijer K, Ruizendaal J, Voordouw A, Weder P et al. Human telomerase reverse transcriptase transduced human cytotoxic T cells suppress the growth of human melanoma in immunodeficient mice. Cancer Res 2004; 64: 2153–2161.
Yee C, Thompson J, Byrd D, Riddell S, Roche P, Celis E et al. Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: In vivo persistence, migration, and antitumor effect of transferred T cells. Proc Natl Acad Sci USA 2002; 99: 16168–16173.
Acknowledgements
We thank Mr M Kester for tetramer synthesis, Dr WN van Wieringen for statistical analysis and Dr R Offringa for critical reading of the manuscript. This work was in part supported by the Dutch Cancer Society and the Deutsche Forschungsgemeinschaft.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hambach, L., Nijmeijer, B., Aghai, Z. et al. Human cytotoxic T lymphocytes specific for a single minor histocompatibility antigen HA-1 are effective against human lymphoblastic leukaemia in NOD/scid mice. Leukemia 20, 371–374 (2006). https://doi.org/10.1038/sj.leu.2404056
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2404056
This article is cited by
-
Towards effective and safe immunotherapy after allogeneic stem cell transplantation: identification of hematopoietic-specific minor histocompatibility antigen UTA2-1
Leukemia (2013)
-
Graft-versus-host driven graft-versus-leukemia effect of minor histocompatibility antigen HA-1 in chronic myeloid leukemia patients
Leukemia (2010)
-
Adoptively transferred human lung tumor specific cytotoxic T cells can control autologous tumor growth and shape tumor phenotype in a SCID mouse xenograft model
Journal of Translational Medicine (2007)